Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$98.98 - $115.74 $166,880 - $195,137
1,686 Added 7.03%
25,658 $2.97 Million
Q2 2023

Aug 11, 2023

SELL
$96.34 - $112.38 $113,584 - $132,496
-1,179 Reduced 4.69%
23,972 $2.47 Million
Q1 2023

May 02, 2023

BUY
$107.32 - $113.5 $43,035 - $45,513
401 Added 1.62%
25,151 $2.75 Million
Q4 2022

Feb 10, 2023

SELL
$62.39 - $113.8 $2,682 - $4,893
-43 Reduced 0.17%
24,750 $2.82 Million
Q3 2022

Nov 09, 2022

SELL
$58.92 - $84.67 $95,803 - $137,673
-1,626 Reduced 6.15%
24,793 $1.53 Million
Q2 2022

Aug 15, 2022

BUY
$79.4 - $116.36 $343,325 - $503,140
4,324 Added 19.57%
26,419 $2.11 Million
Q1 2022

Jun 30, 2022

SELL
$86.42 - $109.81 $4,061 - $5,161
-47 Reduced 0.21%
22,095 $2.33 Million
Q4 2021

Feb 15, 2022

SELL
$98.56 - $119.91 $458,895 - $558,300
-4,656 Reduced 17.37%
22,142 $2.39 Million
Q3 2021

Oct 29, 2021

SELL
$91.91 - $110.37 $193,011 - $231,777
-2,100 Reduced 7.27%
26,798 $2.94 Million
Q2 2021

Aug 16, 2021

SELL
$86.24 - $95.92 $538,482 - $598,924
-6,244 Reduced 17.77%
28,898 $2.71 Million
Q1 2021

May 13, 2021

SELL
$71.83 - $95.48 $228,634 - $303,912
-3,183 Reduced 8.31%
35,142 $3.23 Million
Q4 2020

Feb 12, 2021

BUY
$67.0 - $84.39 $268 - $337
4 Added 0.01%
38,325 $2.8 Million
Q3 2020

Oct 30, 2020

BUY
$55.23 - $79.93 $74,394 - $107,665
1,347 Added 3.64%
38,321 $2.98 Million
Q2 2020

Aug 10, 2020

SELL
$30.2 - $56.98 $126,507 - $238,689
-4,189 Reduced 10.18%
36,974 $2.06 Million
Q1 2020

May 13, 2020

SELL
$24.87 - $38.56 $16,936 - $26,259
-681 Reduced 1.63%
41,163 $1.22 Million
Q4 2019

Feb 13, 2020

BUY
$25.43 - $36.67 $105,992 - $152,840
4,168 Added 11.06%
41,844 $1.52 Million
Q3 2019

Nov 13, 2019

BUY
$23.0 - $27.97 $9,867 - $11,999
429 Added 1.15%
37,676 $1.03 Million
Q2 2019

Aug 14, 2019

BUY
$22.81 - $28.48 $849,604 - $1.06 Million
37,247 New
37,247 $896,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.